News

ECOGENE-21 is collaborating in a study on colchicine

People with COVID-19 in the region are currently taking part in a clinical trial of an anti-inflammatory drug that could help limit the complications associated with the coronavirus.

The ECOGENE-21 group is working with the Montreal Heart Institute to recruit 6,000 people in Quebec with the aim of determining the effectiveness of the treatment by autumn. Diane Brisson, director of the ECOGENE-21 clinical platform, explains the role of her team.

 

Read the article on Radio Canada

Read more

  • News

    MEDTEQ+ Health Orbit Program: 6 Canadian companies to support astronauts and remote communities with health technology innovations

    Deep Breathe Inc, Applications MD, Momentum Health, Nura Medical, ECOGENE-21 and Myomar Molecular are the Canadian companies selected as part of the MEDTEQ+-powered Health Orbit program, which aims to support Canadian companies in the development of technologies to meet telemedicine and autonomous healthcare needs on Earth and in space.
    Read more
  • Works

    A drone successfully delivers medicines over 150 km to help isolated patients

    A drone belonging to Delair, a company based in Toulouse (Haute-Garonne), has made a long-distance delivery of medicines. The 150 km test flight will be used to validate its future use in Quebec to deliver medicines to isolated patients.
    Read more
  • News

    ECOGENE-21 tests drone delivery of medicines and samples in Alma

    People who suffer from rare diseases, or who have very specific medical monitoring needs, could see their treatment improved through the use of drones. To help make this a reality one day, the Saguenay-based ECOGENE-21 group recently took part in tests using small remote-controlled aircraft to deliver medicines or medical samples to remote areas.
    Read more